GEHC GE HealthCare Technologies Inc. - Common Stock
$62,42
Prezzo · Mag 20, 2026
Fondamentali al Apr 29, 2026
Intervallo 52 sett.
$59–$89
12% of range
Rating Analisti
BUY
28 analysts
Prezzo Obiettivo
$80
+28% upside
P/E (TTM)
18.0
ROE
22.1%
Margine di Profitto Netto
10.1%
GEHC Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$62.42
Capitalizzazione di Mercato
—
P/E (TTM)
18.0
EPS (TTM)
$4.55
Ricavi (TTM)
$20.62B
Rendimento div.
—
ROE
22.1%
D/E Debito/Patrimonio
1.0
Intervallo 52 sett.
$59 – $89
GEHC Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$20.62B
2021-12-31
→
2025-12-31
EPS
$4.55
2021-12-31
→
2025-12-31
Flusso di cassa libero
$1.50B
2023-12-31
→
2025-12-31
Margini
10.1%
2023-12-31
→
2025-12-31
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
GEHC
Mediana dei peer
P/E (TTM)
18.0
26.3
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
GEHC
Mediana dei peer
Gross Margin (Margine lordo)
40.0%
61.3%
Operating Margin (Margine Operativo)
13.4%
—
Net Profit Margin (Margine di Profitto Netto)
10.1%
13.7%
ROA
5.9%
9.0%
ROE
22.1%
15.8%
ROIC
10.3%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
GEHC
Mediana dei peer
Debt / Equity (Debito / Patrimonio Netto)
1.0
82.5
Current Ratio (Rapporto corrente)
1.4
1.8
Quick Ratio
0.5
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
GEHC
Mediana dei peer
Revenue YoY (Ricavi YoY)
4.8%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
4.0%
—
EPS YoY
4.8%
—
Net Income YoY (Utile Netto YoY)
4.6%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
GEHC
Mediana dei peer
Payout Ratio (Rapporto di Distribuzione Utili)
3.1%
—
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
Dividend Yield
—
Rapporto di Distribuzione Utili
3.1%
CAGR Dividendi 5Y
—
| Data ex-dividendo | Importo |
|---|---|
| 02 Aprile 2026 | $0,0350 |
| 09 Gennaio 2026 | $0,0350 |
| 24 Ottobre 2025 | $0,0350 |
| 25 Luglio 2025 | $0,0350 |
| 25 Aprile 2025 | $0,0350 |
| 14 Gennaio 2025 | $0,0350 |
| 18 Ottobre 2024 | $0,0300 |
| 19 Luglio 2024 | $0,0300 |
| 18 Aprile 2024 | $0,0300 |
| 12 Gennaio 2024 | $0,0300 |
| 19 Ottobre 2023 | $0,0300 |
| 20 Luglio 2023 | $0,0300 |
| 22 Maggio 2023 | $0,0300 |
GEHC Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
28 analisti
- Acquisto forte 8 28,6%
- Compra 10 35,7%
- Mantieni 9 32,1%
- Vendi 1 3,6%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
19 analisti · 2026-05-18
Mediana
$80.00
← Sotto tutti i target
$62.42
Basso
$65.00
Alto
$98.00
Target mediano
$80.00
+28,2%
Target medio
$79.95
+28,1%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.03%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 31 Marzo 2026 | $0.99 | $1.07 | -0.08% |
| 31 Dicembre 2025 | $1.44 | $1.43 | 0.01% |
| 30 Settembre 2025 | $1.07 | $1.07 | -0.00% |
| 30 Giugno 2025 | $1.06 | $0.94 | 0.12% |
| 31 Marzo 2025 | $1.01 | $0.93 | 0.08% |
Confronto tra pari Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| BSX | — | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| BDX | — | 25.3 | 8.2% | 7.7% | 6.5% | — |
| RMD | $37.77B | 27.1 | 9.8% | 27.2% | 25.0% | 59.4% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| GMED | — | 22.3 | 16.7% | 18.3% | 12.1% | — |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 15
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $20.62B | $19.67B | $19.55B | $18.34B | $17.59B | |
| Gross Profit | $8.25B | $8.21B | $7.92B | $7.18B | $7.17B | |
| R&D Expense | $1.26B | $1.31B | $1.21B | $1.03B | $816M | |
| SG&A Expense | $4.22B | $4.27B | $4.28B | $3.63B | $3.56B | |
| Operating Expenses | $5.49B | $5.58B | $5.49B | $4.66B | $4.38B | |
| Operating Income | $2.76B | $2.62B | $2.44B | $2.52B | $2.79B | |
| Other Non-op | $157M | $55M | $86M | $62M | $123M | |
| Pretax Income | $2.77B | $2.58B | $2.36B | $2.51B | $2.88B | |
| Income Tax | $614M | $531M | $743M | $563M | $600M | |
| Net Income | $2.08B | $1.99B | $1.57B | $1.92B | $2.25B | |
| EPS (Basic) | $4.56 | $4.37 | $3.05 | $4.22 | $4.95 | |
| EPS (Diluted) | $4.55 | $4.34 | $3.03 | $4.22 | $4.95 | |
| Shares (Basic) | 456,000,000 | 456,000,000 | 455,000,000 | 454,000,000 | 454,000,000 | |
| Shares (Diluted) | 458,000,000 | 459,000,000 | 458,000,000 | 454,000,000 | 454,000,000 | |
| EBITDA | $2.76B | $2.62B | $2.44B | · | · |
Stato Patrimoniale 28
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.49B | $2.87B | $2.49B | $1.44B | · | |
| Inventory | $2.23B | $1.94B | $1.96B | $2.15B | · | |
| Other Current Assets | $726M | $532M | $389M | $417M | · | |
| Current Assets | $12.50B | $9.90B | $9.41B | $8.32B | · | |
| PP&E (Net) | · | · | $2.14B | $2.00B | · | |
| PP&E (Gross) | $5.73B | $5.27B | $5.21B | $4.99B | · | |
| Accum. Depreciation | $3.05B | $3.08B | $3.06B | $2.99B | · | |
| Goodwill | $13.49B | $13.14B | $12.94B | $12.81B | $12.89B | |
| Intangibles | $1.13B | $1.08B | $1.25B | $1.52B | · | |
| Other Non-current Assets | $2.21B | $1.95B | $1.88B | $1.02B | · | |
| Total Assets | $36.91B | $33.09B | $32.45B | $27.54B | · | |
| Accounts Payable | $3.25B | $3.04B | $2.95B | $2.94B | · | |
| Short-term Debt | $508M | $1.50B | $1.01B | $15M | · | |
| Current Liabilities | $9.11B | $9.55B | $8.98B | $7.19B | · | |
| Capital Leases | $284M | $270M | $273M | $243M | · | |
| Deferred Tax | $193M | $56M | $68M | $370M | · | |
| Other Non-current Liabilities | $2.06B | $1.80B | $1.88B | $1.60B | · | |
| Total Liabilities | $26.31B | $24.44B | $25.14B | $17.95B | · | |
| Long-term Debt | $10.00B | $8.95B | $9.44B | $8.25B | · | |
| Total Debt | $10.51B | $10.45B | $9.44B | · | · | |
| Common Stock | $5M | $5M | $5M | $0 | · | |
| Paid-in Capital | $6.71B | $6.58B | $6.49B | $0 | · | |
| Retained Earnings | $5.28B | $3.26B | $1.33B | $0 | · | |
| Treasury Stock | $225M | $25M | $0 | · | · | |
| AOCI | $-1.39B | $-1.38B | $-691M | $-1.88B | · | |
| Stockholders' Equity | $10.38B | $8.45B | $7.13B | $9.36B | · | |
| Liabilities + Equity | $36.91B | $33.09B | $32.45B | $27.54B | · | |
| Shares Outstanding | · | · | 455,342,290 | 0 | 0 |
Flusso di cassa 13
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $130M | $125M | $114M | $67M | $76M | |
| Amort. of Intangibles | $291M | $312M | $362M | $405M | $400M | |
| Restructuring | $102M | $93M | $37M | $146M | $155M | |
| Operating Cash Flow | $1.99B | $1.96B | $2.10B | $2.13B | $1.61B | |
| CapEx | $482M | $401M | $387M | $310M | $248M | |
| Investing Cash Flow | $-1.05B | $-914M | $-558M | $-398M | $-1.76B | |
| Stock Repurchased | $200M | $0 | $0 | · | · | |
| Net Stock Activity | $-200M | · | · | · | · | |
| Dividends Paid | $64M | $55M | $41M | $0 | $0 | |
| Financing Cash Flow | $617M | $-573M | $-478M | $-822M | $-263M | |
| Net Change in Cash | $1.62B | $387M | $1.05B | $890M | $-451M | |
| Taxes Paid | $429M | $491M | $474M | $851M | $615M | |
| Free Cash Flow | $1.50B | $1.55B | $1.71B | · | · |
Redditività 8
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Gross Margin | 40.0% | 41.7% | 40.5% | · | · | |
| Operating Margin | 13.4% | 13.3% | 12.4% | · | · | |
| Net Margin | 10.1% | 10.1% | 8.0% | · | · | |
| Pretax Margin | 13.4% | 13.1% | 12.1% | · | · | |
| EBITDA Margin | 13.4% | 13.3% | 12.4% | · | · | |
| ROA | 5.9% | 6.1% | 5.2% | · | · | |
| ROE | 22.1% | 25.6% | 19.0% | · | · | |
| ROIC | 10.3% | 11.0% | 10.1% | · | · |
Liquidità e Solvibilità 4
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.0 | 1.0 | · | · | |
| Quick Ratio | 0.5 | 0.3 | 0.3 | · | · | |
| Debt / Equity | 1.0 | 1.2 | 1.3 | · | · | |
| LT Debt / Equity | 0.9 | 0.9 | 1.2 | · | · |
Efficienza 1
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.7 | · | · |
Tassi di Crescita 6
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | 4.8% | 0.61% | 6.6% | 4.3% | · | |
| Revenue CAGR 3Y | 4.0% | 3.8% | · | · | · | |
| EPS YoY | 4.8% | 43.2% | -28.2% | -14.8% | · | |
| EPS CAGR 3Y | 2.5% | -4.3% | · | · | · | |
| Net Income YoY | 4.6% | 27.1% | -18.2% | -14.7% | · | |
| Net Income CAGR 3Y | 2.8% | -3.9% | · | · | · |
Valutazione (TTM) 16
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $20.62B | $19.67B | $19.55B | $18.34B | · | |
| Net Income TTM | $2.08B | $1.99B | $1.57B | $1.92B | · | |
| Market Cap | · | · | $35.21B | · | · | |
| Enterprise Value | · | · | $42.16B | · | · | |
| P/E | 18.0 | 18.0 | 25.5 | 13.8 | · | |
| P/S | · | · | 1.8 | · | · | |
| P/B | · | · | 4.9 | · | · | |
| P / Cash Flow | · | · | 16.8 | · | · | |
| P / FCF | · | · | 20.5 | · | · | |
| EV / EBITDA | · | · | 17.3 | · | · | |
| EV / FCF | · | · | 24.6 | · | · | |
| EV / Revenue | · | · | 2.2 | · | · | |
| Dividend Yield | · | · | 0.12% | · | · | |
| Earnings Yield | 5.5% | 5.5% | 3.9% | 7.2% | · | |
| Payout Ratio | 3.1% | 2.8% | 2.6% | · | · | |
| Annual Payout | $64M | $55M | $41M | $0 | · |
Conto Economico 15
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.13B | $5.70B | $5.14B | $5.01B | $4.78B | $5.32B | $4.86B | $4.84B | $4.65B | $5.21B | $4.82B | $4.82B | $4.71B | $4.94B | $4.58B | $4.48B | |
| Gross Profit | $1.98B | $2.26B | $1.99B | $1.99B | $2.01B | $2.27B | $2.03B | $2.00B | $1.90B | $2.16B | $1.94B | $1.94B | $1.89B | $1.93B | $1.77B | $1.80B | |
| R&D Expense | $345M | $322M | $292M | $302M | $344M | $344M | $316M | $327M | $324M | $315M | $322M | $298M | $270M | $271M | $260M | $257M | |
| SG&A Expense | $1.12B | $1.11B | $1.04B | $1.03B | $1.04B | $1.13B | $1.03B | $1.07B | $1.04B | $1.15B | $996M | $1.07B | $1.06B | $884M | $908M | $908M | |
| Operating Expenses | $1.46B | $1.43B | $1.34B | $1.33B | $1.38B | $1.47B | $1.35B | $1.40B | $1.36B | $1.47B | $1.32B | $1.37B | $1.33B | $1.16B | $1.17B | $1.17B | |
| Operating Income | $515M | $827M | $653M | $654M | $629M | $801M | $676M | $608M | $540M | $689M | $617M | $570M | $559M | $777M | $605M | $631M | |
| Other Non-op | $36M | $33M | $26M | $-1M | $99M | $53M | $9M | $1M | $-8M | $1M | $63M | $14M | $8M | $-1M | $18M | $19M | |
| Pretax Income | $505M | $820M | $643M | $613M | $692M | $833M | $658M | $578M | $512M | $609M | $636M | $570M | $546M | $718M | $622M | $639M | |
| Income Tax | $94M | $218M | $179M | $113M | $104M | $96M | $168M | $143M | $124M | $193M | $250M | $137M | $163M | $150M | $129M | $153M | |
| Net Income | $389M | $588M | $446M | $486M | $564M | $721M | $470M | $428M | $374M | $403M | $375M | $418M | $372M | $555M | $487M | $485M | |
| EPS (Basic) | $0.85 | $1.29 | $0.98 | $1.06 | $1.23 | $1.58 | $1.03 | $0.94 | $0.82 | $0.89 | $0.82 | $0.92 | $0.42 | $1.22 | $1.07 | $1.07 | |
| EPS (Diluted) | $0.85 | $1.28 | $0.98 | $1.06 | $1.23 | $1.58 | $1.02 | $0.93 | $0.81 | $0.89 | $0.82 | $0.91 | $0.41 | $1.22 | $1.07 | $1.07 | |
| Shares (Basic) | 456,000,000 | -914,000,000 | 456,000,000 | 457,000,000 | 457,000,000 | -914,000,000 | 457,000,000 | 457,000,000 | 456,000,000 | -909,000,000 | 455,000,000 | 455,000,000 | 454,000,000 | -908,000,000 | 454,000,000 | 454,000,000 | |
| Shares (Diluted) | 457,000,000 | -916,000,000 | 457,000,000 | 458,000,000 | 459,000,000 | -918,000,000 | 459,000,000 | 459,000,000 | 459,000,000 | -915,000,000 | 458,000,000 | 458,000,000 | 457,000,000 | -908,000,000 | 454,000,000 | 454,000,000 | |
| EBITDA | $515M | · | $653M | $654M | $629M | · | $676M | $608M | $540M | · | $617M | $570M | $559M | · | · | · |
Stato Patrimoniale 27
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.26B | $4.49B | $4.00B | $3.74B | $2.45B | $2.87B | $3.55B | $2.00B | $2.55B | · | $2.41B | $1.94B | $2.32B | · | · | · | |
| Inventory | $2.35B | $2.23B | $2.30B | $2.28B | $2.16B | $1.94B | $2.12B | $2.02B | $1.99B | · | $2.13B | $2.26B | $2.26B | · | · | · | |
| Other Current Assets | $842M | $726M | $702M | $638M | $601M | $532M | $476M | $437M | $517M | · | $484M | $596M | $634M | · | · | · | |
| Current Assets | $10.43B | $12.50B | $11.89B | $11.31B | $9.73B | $9.90B | $10.64B | $8.81B | $9.37B | · | $9.47B | $9.24B | $9.60B | · | · | · | |
| PP&E (Gross) | $5.69B | $5.73B | $5.89B | $5.84B | $5.66B | $5.27B | $5.36B | $5.21B | $5.18B | · | $5.01B | $5.08B | $5.06B | · | · | · | |
| Accum. Depreciation | $2.99B | $3.05B | $3.29B | $3.27B | $3.18B | $3.08B | $3.18B | $3.11B | $3.09B | · | $3.00B | $3.06B | $3.04B | · | · | · | |
| Goodwill | $15.06B | $13.49B | $13.44B | $13.42B | $13.37B | $13.14B | $13.14B | $13.12B | $12.93B | $12.94B | $12.91B | $12.93B | $12.92B | $12.81B | · | · | |
| Intangibles | $1.91B | $1.13B | $1.16B | $1.22B | $1.24B | $1.08B | $1.13B | $1.20B | $1.17B | · | $1.33B | $1.42B | $1.49B | · | · | · | |
| Other Non-current Assets | $2.25B | $2.21B | $2.15B | $2.08B | $1.93B | $1.95B | $2.10B | $1.91B | $1.88B | · | $2.04B | $2.01B | $1.95B | · | · | · | |
| Total Assets | $37.12B | $36.91B | $36.13B | $35.50B | $33.59B | $33.09B | $33.85B | $31.85B | $32.21B | · | $32.38B | $32.31B | $32.64B | · | · | · | |
| Accounts Payable | $3.41B | $3.25B | $2.99B | $2.98B | $3.15B | $3.04B | $2.91B | $2.82B | $2.93B | · | $2.77B | $2.83B | $2.98B | · | · | · | |
| Short-term Debt | $7M | $508M | $2.00B | $2.00B | $2.00B | $1.50B | $1.01B | $1.01B | $1.01B | · | $7M | $5M | $5M | · | · | · | |
| Current Liabilities | $8.53B | $9.11B | $10.07B | $9.75B | $9.97B | $9.55B | $8.67B | $8.32B | $8.86B | · | $7.57B | $7.58B | $8.24B | · | · | · | |
| Capital Leases | $270M | $284M | $285M | $271M | $266M | $270M | $263M | $267M | $267M | · | · | · | · | · | · | · | |
| Deferred Tax | $256M | $193M | $171M | $173M | $159M | $56M | $59M | $55M | $68M | · | $62M | $81M | $64M | · | · | · | |
| Other Non-current Liabilities | $2.02B | $2.06B | $2.10B | $2.00B | $1.84B | $1.80B | $1.92B | $1.80B | $1.81B | · | $1.83B | $1.93B | $1.83B | · | · | · | |
| Total Liabilities | $26.23B | $26.31B | $25.91B | $25.55B | $24.17B | $24.44B | $25.34B | $23.86B | $24.61B | · | $25.08B | $24.99B | $25.74B | · | · | · | |
| Long-term Debt | $10.13B | $10.00B | $10.28B | $10.28B | $8.76B | $8.95B | $10.31B | $9.24B | $9.26B | · | $10.26B | $10.24B | $10.24B | · | · | · | |
| Total Debt | $10.14B | · | $12.28B | $12.28B | $10.76B | · | $11.32B | $10.24B | $10.26B | · | $10.27B | $10.24B | $10.24B | · | · | · | |
| Common Stock | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | · | · | · | |
| Paid-in Capital | $6.73B | $6.71B | $6.66B | $6.63B | $6.60B | $6.58B | $6.55B | $6.54B | $6.50B | · | $6.47B | $6.45B | $6.42B | · | · | · | |
| Retained Earnings | $5.65B | $5.28B | $4.71B | $4.29B | $3.81B | $3.26B | $2.56B | $2.10B | $1.69B | · | $937M | $576M | $185M | · | · | · | |
| Treasury Stock | $325M | $225M | $225M | $125M | $25M | $25M | $25M | · | · | · | · | · | · | · | · | · | |
| AOCI | $-1.40B | $-1.39B | $-1.16B | $-1.09B | $-1.20B | $-1.38B | $-771M | $-845M | $-787M | · | $-280M | $70M | $75M | · | · | · | |
| Stockholders' Equity | $10.67B | $10.38B | $9.99B | $9.71B | $9.19B | $8.45B | $8.32B | $7.80B | $7.41B | · | $7.13B | $7.10B | $6.69B | · | · | · | |
| Liabilities + Equity | $37.12B | $36.91B | $36.13B | $35.50B | $33.59B | $33.09B | $33.85B | $31.85B | $32.21B | · | $32.38B | $32.31B | $32.64B | · | · | · | |
| Shares Outstanding | · | · | · | · | · | · | · | 456,654,068 | 456,328,270 | · | 455,224,438 | 454,808,732 | 454,617,131 | · | · | · |
Flusso di cassa 14
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $35M | $36M | $38M | $34M | $22M | $33M | $22M | $36M | $34M | $33M | $29M | $28M | $24M | $9M | $19M | $20M | |
| Amort. of Intangibles | $75M | $72M | $74M | $75M | $70M | $74M | $77M | $81M | $80M | $84M | $89M | $93M | $96M | $98M | $103M | $101M | |
| Restructuring | $44M | $40M | $30M | $12M | $20M | $2M | $22M | $29M | $40M | · | $3M | $19M | $12M | · | $88M | $10M | |
| Operating Cash Flow | $290M | $1.05B | $593M | $94M | $250M | $913M | $742M | $-119M | $419M | $1.05B | $650M | $-67M | $468M | $1.06B | $622M | $-19M | |
| CapEx | $178M | $134M | $110M | $86M | $152M | $102M | $90M | $64M | $145M | $94M | $80M | $70M | $143M | $77M | $74M | $59M | |
| Investing Cash Flow | $-2.50B | $-269M | $-148M | $-223M | $-407M | $-240M | $-137M | $-349M | $-188M | $-88M | $-120M | $-84M | $-266M | $-95M | $-118M | $-85M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Stock Repurchased | $100M | $0 | $100M | $100M | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-100M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $16M | $16M | $16M | $16M | $16M | $14M | $13M | $14M | $14M | $13M | $14M | $14M | $0 | $0 | $0 | · | |
| Financing Cash Flow | $21M | $-293M | $-165M | $1.36B | $-286M | $-1.28B | $914M | $-57M | $-153M | $-900M | $-24M | $-227M | $673M | $-37M | $-505M | $140M | |
| Net Change in Cash | $-2.23B | $486M | $264M | $1.29B | $-416M | $-679M | $1.55B | $-547M | $59M | $86M | $475M | $-389M | $883M | $947M | $-26M | $24M | |
| Taxes Paid | $92M | $76M | $83M | $179M | $91M | $116M | $88M | $201M | $86M | $99M | $104M | $169M | $102M | $187M | $221M | $240M | |
| Free Cash Flow | $112M | · | · | · | $98M | · | · | · | $274M | · | · | · | $325M | · | · | · |
Redditività 8
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.5% | · | 38.7% | 39.6% | 42.1% | · | 41.7% | 41.4% | 40.9% | · | 40.1% | 40.3% | 40.2% | · | · | · | |
| Operating Margin | 10.0% | · | 12.7% | 13.1% | 13.2% | · | 13.9% | 12.6% | 11.6% | · | 12.8% | 11.8% | 11.9% | · | · | · | |
| Net Margin | 7.6% | · | 8.7% | 9.7% | 11.8% | · | 9.7% | 8.8% | 8.0% | · | 7.8% | 8.7% | 7.9% | · | · | · | |
| Pretax Margin | 9.8% | · | 12.5% | 12.2% | 14.5% | · | 13.5% | 11.9% | 11.0% | · | 13.2% | 11.8% | 11.6% | · | · | · | |
| EBITDA Margin | 10.0% | · | 12.7% | 13.1% | 13.2% | · | 13.9% | 12.6% | 11.6% | · | 12.8% | 11.8% | 11.9% | · | · | · | |
| ROA | 1.1% | · | 1.3% | 1.4% | 1.7% | · | 1.4% | 1.3% | 1.1% | · | 2.3% | 2.6% | 2.3% | · | · | · | |
| ROE | 3.9% | · | 4.9% | 5.5% | 6.8% | · | 6.1% | 5.7% | 5.3% | · | 10.5% | 11.8% | 11.1% | · | · | · | |
| ROIC | 2.0% | · | 2.1% | 2.4% | 2.7% | · | 2.6% | 2.5% | 2.3% | · | 2.1% | 2.5% | 2.3% | · | · | · |
Liquidità e Solvibilità 4
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | · | 1.2 | 1.2 | 1.0 | · | 1.2 | 1.1 | 1.1 | · | 1.3 | 1.2 | 1.2 | · | · | · | |
| Quick Ratio | 0.3 | · | 0.4 | 0.4 | 0.2 | · | 0.4 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | · | · | |
| Debt / Equity | 1.0 | · | 1.2 | 1.3 | 1.2 | · | 1.4 | 1.3 | 1.4 | · | 1.4 | 1.4 | 1.5 | · | · | · | |
| LT Debt / Equity | 0.9 | · | 0.8 | 0.9 | 0.7 | · | 1.1 | 1.1 | 1.1 | · | 1.4 | 1.4 | 1.5 | · | · | · |
Efficienza 1
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.3 | 0.3 | 0.3 | · | · | · |
Valutazione (TTM) 14
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20.06B | · | $19.79B | $19.49B | $19.13B | · | $19.17B | $19.13B | $19.00B | · | $18.92B | $18.58B | $18.11B | · | · | · | |
| Net Income TTM | $1.89B | · | $1.97B | $1.95B | $1.84B | · | $1.65B | $1.59B | $1.54B | · | $1.65B | $1.76B | $1.73B | · | · | · | |
| Market Cap | · | · | · | · | · | · | · | $35.58B | $41.48B | · | $30.97B | $36.95B | $37.29B | · | · | · | |
| Enterprise Value | · | · | · | · | · | · | · | $43.83B | $49.19B | · | $38.83B | $45.26B | $45.21B | · | · | · | |
| P/E | 17.3 | · | 17.5 | 17.5 | 20.2 | · | 26.2 | 22.5 | 30.8 | · | 21.2 | 23.5 | 24.1 | · | · | · | |
| P/S | · | · | · | · | · | · | · | 1.9 | 2.2 | · | 1.6 | 2.0 | 2.1 | · | · | · | |
| P/B | · | · | · | · | · | · | · | 4.6 | 5.6 | · | 4.3 | 5.2 | 5.6 | · | · | · | |
| P / Cash Flow | · | · | · | · | · | · | · | · | 99.0 | · | · | · | 79.7 | · | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | 151.4 | · | · | · | 114.7 | · | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | 72.1 | 91.1 | · | 62.9 | 79.4 | 80.9 | · | · | · | |
| EV / FCF | · | · | · | · | · | · | · | · | 179.5 | · | · | · | 139.1 | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | 2.3 | 2.6 | · | 2.1 | 2.4 | 2.5 | · | · | · | |
| Earnings Yield | 5.8% | · | 5.7% | 5.7% | 4.9% | · | 3.8% | 4.5% | 3.2% | · | 4.7% | 4.3% | 4.2% | · | · | · | |
| Payout Ratio | 4.1% | · | · | · | 2.8% | · | · | · | 3.7% | · | · | · | · | · | · | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $20.62B | $19.67B | $19.55B | $18.34B | $17.59B |
| Margine Lordo % | 40.0% | 41.7% | 40.5% | — | — |
| Margine Operativo % | 13.4% | 13.3% | 12.4% | — | — |
| Utile netto | $2.08B | $1.99B | $1.57B | $1.92B | $2.25B |
| EPS Diluito | $4.55 | $4.34 | $3.03 | $4.22 | $4.95 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 1.0 | 1.2 | 1.3 | — | — |
| Rapporto corrente | 1.4 | 1.0 | 1.0 | — | — |
| Quick Ratio | 0.5 | 0.3 | 0.3 | — | — |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $1.50B | $1.55B | $1.71B | — | — |
Ultime notizie Notizie recenti che menzionano questa società
- Aggiornamento del mercato: HWM, CSCO, ITRI, VLO, XYL, GEHC
- Wall Street è rialzista o ribassista sul titolo GE HealthCare Technologies?
- Ecco perché le azioni di GE Healthcare sono crollate questa settimana
- Le azioni di GE HealthCare crollano dopo aver mancato gli utili e tagliato le previsioni
- La famiglia GE divisa: confronto tra valutazioni, tassi di crescita e sentiment degli analisti in 3 settori
- Bank of America Corp Rompe la Media Móvil de 200 Días - Alcista para BAC
- GE HealthCare (GEHC) Riceve l'Autorizzazione FDA per il Sistema CT Photonova Spectra
- Il Futuro È Adesso: 2 Azioni AI per la Diagnostica Medica da Acquistare
Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.